Showing results (2521-2530 of 9,653) with videos related to
Sort By:
Pageof 966
Leukemia|January 17, 2009
Molecular evidence for EBV and CMV persistence in a subset of patients with chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptorsE Kostareli, A Hadzidimitriou, N Stavroyianni, et al.Leukemia|February 6, 2009
Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignanciesJ Iqbal, C Kucuk, R J Deleeuw, et al.Leukemia|October 27, 2010
Analysis of CD16+CD56dim NK cells from CLL patients: evidence supporting a therapeutic strategy with optimized anti-CD20 monoclonal antibodiesM Le Garff-Tavernier, J Decocq, C de Romeuf, et al.Leukemia|November 6, 2010
A phase-2 trial of low-dose pomalidomide in myelofibrosisK H Begna, R A Mesa, A Pardanani, et al.Leukemia|March 12, 2011
Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21)E Drakos, R R Singh, G Z Rassidakis, et al.Leukemia|March 5, 2011
Meta-analysis of randomised trials comparing thiopurines in childhood acute lymphoblastic leukaemiaG Escherich, S Richards, L C Stork, et al.Leukemia|July 1, 1990
Mutation of the human FMS gene (M-CSF receptor) in myelodysplastic syndromes and acute myeloid leukemiaK Tobal, A Pagliuca, B Bhatt, et al.Leukemia|October 14, 2018
Inhibitors of the protein disulfide isomerase family for the treatment of multiple myelomaReeder M Robinson, Leticia Reyes, Ravyn M Duncan, et al.Leukemia|October 14, 2018
Relative survival following response to 7 + 3 versus azacytidine is similar in acute myeloid leukemia and high-risk myelodysplastic syndromes: an analysis of four SWOG studiesMegan Othus, Mikkael A Sekeres, Sucha Nand, et al.Pageof 966